ED
NTB icon

Exane Derivatives’s Bank of N.T. Butterfield & Son NTB Stock Holding History

Exane Derivatives’s Portfolio NTB Stock Details NTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,699
Closed -$59.4K – 1067
2021
Q2 		$59.4K Buy
+1,699
New +$64.3K 0.01% 627

Other funds holding NTB

DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exane Derivatives's NTB Position: Q3 2021 in Review

Exane Derivatives sold out of Bank of N.T. Butterfield & Son (NTB) in Q3 2021, closing a stake of 1,699 shares — an estimated $59.4K sold.

Exane Derivatives first reported a position in NTB in Q2 2021 and held it in 1 quarter. The position peaked at $59.4K in Q2 2021. 142 funds tracked by Wall St. Rank hold NTB as of Q3 2021.

  • Exane Derivatives reported no remaining Bank of N.T. Butterfield & Son position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 1,699 Bank of N.T. Butterfield & Son shares in Q3 2021, an estimated $59.4K.
  • Exane Derivatives first reported a position in Bank of N.T. Butterfield & Son in Q2 2021 and held it in 1 quarter.
  • Exane Derivatives's Bank of N.T. Butterfield & Son position peaked at $59.4K in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Bank of N.T. Butterfield & Son as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.